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Background: This study was conducted to clarify the effect of the inhibiting action of inhibin on porcine granulosa
cell proliferation and function, and to investigate the underlying intracellular regulatory molecular mechanisms.
Methods: Porcine granulosa cells were cultured in vitro, and were treated with an anti-inhibin alpha subunit antibody,
with or without co-treatment of follicle-stimulating hormone (FSH) in the culture medium.
Results: Treatment with anti-inhibin alpha subunit antibody led to a significant increase in estradiol (E2) secretion
and cell proliferation. Anti-inhibin alpha subunit antibody worked synergistically with FSH at low concentrations
(25 microg/mL) to stimulate E2 secretion, but attenuated FSH action at high concentrations (50 microg/mL).
Immunoneutralization of inhibin bioactivity increased FOXL2, Smad3, and PKA phosphorylation, and mRNA expression
of the transcription factors CEBP and c-FOS. The expression of genes encoding gonadotropin receptors, FSHR and LHR,
and of those involved in steroidogenesis, as well as IGFs and IGFBPs, the cell cycle progression factors cyclinD1 and
cyclinD2, and the anti-apoptosis and anti-atresia factors Bcl2, TIMP, and ADAMTS were upregulated following anti-inhibin
alpha-subunit treatment. Treatment with anti-inhibin alpha subunit down regulated expression of the pro-apoptotic gene
encoding caspase3. Although expression of the pro-angiogenesis genes FN1, FGF2, and VEGF was upregulated, expression
of the angiogenesis-inhibiting factor THBS1 was downregulated following anti-inhibin alpha subunit treatment.
Conclusions: These results suggest that immunoneutralization of inhibin bioactivity, through augmentation of the
activin and gonadotropin receptor signaling pathways and regulation of gene expression, permits the development of
healthy and viable granulosa cells. These molecular mechanisms help to explain the enhanced ovarian follicular
development observed following inhibin immunization in animal models.
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The hormone inhibin is a dimeric glycoprotein that is
primarily secreted by the gonads and plays important
roles in the regulation of reproductive activities in animals
[1]. Inhibin inhibits the pituitary secretion of follicle-
stimulating hormone (FSH) through negative feedback
regulation [2,3]. Furthermore, inhibin derived from dom-
inant or large mature follicles is believed to inhibit the
development of subordinate follicles through a paracrine
effect, representing a mechanism of follicular selection.
Through these central and local actions, inhibin is in-
volved in follicular selection and determination of the
ovulation rate [4]. In this regard, inhibin has been viewed
as a negative regulator of ovarian follicle development [5].
This response has been exploited in inhibin-immunized
animals in an attempt to neutralize the biological activities
of inhibin and to stimulate ovarian follicular development.
Such treatments have resulted in enhanced ovarian fol-
licular development [6], ovulation rate [7], litter size,
and embryo quantity and quality following superovulation
[8-10]. The stimulation of follicular development by in-
hibin immunization is accompanied by enhanced secre-
tion of estradiol (E2) [7,9,10], although its role in the
elevation of pituitary FSH secretion remains unclear [11].
This suggests that immunoneutralization of inhibin bio-
activity may directly stimulate follicular or granulosa cell
function, apart from the stimulation induced by enhanced
FSH secretion. This notion is supported by evidence of
direct stimulation of E2 secretion by cultured bovine
granulosa cells treated with an antibody against the
inhibin α-subunit [12]. Apart from enhanced E2 secre-
tion, the mechanism underlying the enhanced growth
and development of ovarian follicles following inhibin
immunization remains unknown. Therefore, this study
was performed to evaluate the molecular regulation of
granulosa cell function by investigating the proliferation
of E2-secreting cells and the expression of key molecules
involved following the treatment of cultured porcine
granulosa cells with anti-inhibin α-subunit antibody.
Methods
Granulosa cell culture
Ovaries of prepubertal gilts aged 165–180 days were ob-
tained from a local slaughterhouse and transported to
the laboratory in a vacuum thermos flask in sterile
physiological saline at 30–37°C within 2 h of isolation.
After ovaries were washed three times with sterile
physiological saline at 37°C, follicular fluid and granulosa
cells were aspirated from 40 medium-sized follicles, be-
tween 4 and 6 mm in diameter, that contained clear fol-
licle fluid, by using a 10-mL syringe. The cells were then
transferred to a 15-mL centrifuge tube, and 1 mL of
0.25% trypsin was added to digest cell lumps. Following
incubation at 37°C for 3–5 min to disperse clumps ofcells, 1 mL of 10% fetal calf serum-supplemented Dulbec-
co’s modified Eagle’s medium/Ham’s F-12 nutrient mixture
(DMEM/F12, without phenol red) was added to the tube
to terminate trypsin digestion. The cells were then centri-
fuged at 800 g for 15 min to be precipitated and then
washed twice with phosphate-buffered saline (PBS).
Cell density was adjusted to 1 × 10(5) cells per well in
a 96-well plate, in 200 μL of culture medium containing
10% fetal calf serum (FCS), and cell survival rate was
measured by the trypan blue exclusion test, which was
66 +/− 7%. The cells were incubated under a humidified
atmosphere containing 5% CO2 at 37°C for 24 h, and
then washed with PBS to remove any unattached cells.
Then, the culture medium was changed and replaced
with new DMEM/F12 medium containing 2% FCS,
0.1 μM androstenedione, and a polyclonal anti-inhibin
α-subunit antibody at a final concentration of 0, 25, 50,
100, 200, or 300 μg/mL. For the FSH treatment, different
concentrations of FSH (0, 10, 20, or 50 ng/mL) were
added to the medium, or combined with different doses
of anti-inhibin α-subunit antibody (0, 25, 50, or 100 μg/
mL). The plates were incubated for a further 48 h under
a humidified atmosphere at 5% CO2 and 37°C. At the
end of each incubation period, aliquots of the culture
medium were collected for measuring E2 concentration.
Each treatment combination was replicated in 3 culture
wells in one experiment, and each experiment was re-
peated by 6 times.
For measurements of mRNA gene expression and
phosphorylated protein levels, cells were plated at a
density of 2 × 10(6) cells per well in a 6-well plate, in
2000 μL of culture medium (DMEM/F12 containing
10% FCS). Following the initial culture for 24 h and
washing with PBS as described above, cells were further
cultured for 48 h in the DMEM/F12 medium containing
2% FCS, 0.1 μM androstenedione, and an anti-inhibin
α-subunit antibody [6], at a final concentration of 0, 50,
and 200 μg/mL, respectively. Then, the culture medium
was carefully aspirated out, and 200 μL TRIzol (Invitro-
gen), for RNA extraction, or radio-immunoprecipitation
assay buffer (RIPA; Beyotime Institute of Biotechnology)
supplemented with 0.1% sodium dodecyl sulfate (SDS),
for protein extraction, was added to each well. After di-
gestion of the cells for 5 min, lysates were aspirated and
stored frozen at −80°C until further analysis.
Measurement of E2 concentration
Concentrations of E2 in the culture medium were mea-
sured by enzyme-linked immunosorbent assay (Beijing
North Institute of Biological Technology; Beijing, China),
according to the manufacturer’s instructions. The stand-
ard curve ranged from 40 to 1000 pg/mL for E2. Condi-
tioned supernatants were diluted in FCS-free medium.
Depending on the E2 concentration in the conditioned
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times, respectively, for treatment with each antibody con-
centration to ensure that the final value fell within the
detection range of the standard curve. Each sample was
assayed in duplicate, and the E2 concentration was calcu-
lated by multiplying the end value by the dilution factor.
The assay sensitivity, range, and intra-assay coefficient of
variation were 1 pg/mL, 1–1000 pg/mL, and <15%, re-
spectively. All samples were used in a single assay.
Measurement of cell proliferation
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium brom-
ide (MTT) is converted into yellow formazan after being
reduced by succinate dehydrogenase, which is synthe-
sized by the mitochondria of live cells. Therefore, the
production of formazan is proportional to the number
of live cells, which was used to represent granulosa cell
proliferation in the present study. Following granulosa
cell culture as described above for 24, 48, and 72 h,
10 μL of MTT solution containing 5 mg/mL thiazolyl
blue MTT was added to each well of Cell Counting Kit
8 (Shanghai QCBio Science & Technologies CO., Ltd.;
Shanghai, China). The cells were cultured for a further
3 h and the optical density (OD) of the yellow color
was measured at 490 nm by using a Biotek EON micro-
titer plate reader. Each treatment was repeated by 2
duplicate wells, and then repeated by 6 independent
experiments.
Western blotting
RIPA lysates from 2 culture wells of the same antibody
treatment were combined and centrifuged for 15 min.
The pellet was discarded and the protein concentration
in the supernatant was measured by the BCA assay
(Applygen Technologies, Inc.; Beijing, China). Thirty mi-
crograms of protein-lysate from each sample was loaded
and separated by 12% SDS-polyacrylamide gel electro-
phoresis, and proteins were transferred onto polyvinyli-
dene fluoride membranes. The membranes were then
blocked using 5% (w/v) fat-free dry milk/Tris-buffered
saline (TBS) at 4°C overnight, and then washed with
TBS/0.05% Tween 20 three times for 20 min each.
Membranes were then incubated with primary antibody
against phosphorylated forms of Smad3 (Santa Cruz Bio-
technology, Inc.), PKA (Millipore), and FOXL2 (Bioss),
or β-actin (13E5) (Cell Signaling Technology, Inc.; Bos-
ton, MA) for 2 h at room temperature, and washed three
times for 20 min each. The membranes were incubated
with a goat anti-rabbit IgG-horseradish peroxidase-
conjugated secondary antibody (Santa Cruz Biotechnology,
Inc.) diluted 1:5000 in 5% (w/v) fat-free dry milk/TBS for
1 h at room temperature. Membranes were washed three
times and signals were visualized using SuperSignal West-
Pico kit (Thermo Fisher Scientific; Waltham, MA, USA).The band intensity was normalized to that of β-actin. The
final result was calculated as the mean of 4 independent
cell cultures.Measurements of gene expression levels
Real-time quantitative polymerase chain reaction (qPCR)
was performed to quantify the mRNA expression levels
of β-actin, cytochrome P450 aromatase (P450arom),
cholesterol side-chain cleavage cytochrome P450 (P450scc),
steroidogenic acute regulated protein (StAR), inhibin-α,
inhibin-β, FSHR, LHR, fibroblast growth factor (FGF2),
vascular endothelial cell growth factor (VEGF), throm-
bospondin 1 (THBS1), insulin-like growth factors (IGFs),
IGFBPs, CyclinD1, CyclinD2, cyclin-dependent kinase in-
hibitor 1B (P27Kip), BCL, caspase3, A disintegrin and me-
talloproteinase with thrombospondin motifs (ADAMTS),
tissue inhibitor of metalloproteases (TIMP), forkhead box
L2 (FOXL2), CCAAT/enhancer binding proteins (CEBP),
and FBJ murine osteosarcoma viral oncogene homolog
(FOS) in the cultured granulosa cells (Table 1). Total RNA
was extracted from the TRIzol lysate, combined from 3
culture wells for each antibody treatment, and was
reverse-transcribed using ReverTra Ace qPCR-RT Kit
(Toyobo; Osaka, Japan) to generate template cDNA. PCRs
were carried out in a 50-μL reaction volume containing
SYBR Green I Master Mix (Toyobo) and 2.5 pmol rele-
vant primers set as indicated in Table 1. An ABI
PRISM_7500 sequence detection system (Applied Bio-
systems; Foster City, CA, USA) was used to detect the
amplification products. Upon completion of the real-
time qPCR, threshold cycle (Ct, defined as the cycle at
which a statistically significant increase in the magni-
tude of the signal generated by PCR was first detected)
values were calculated by sequence detection software
SDS Version 1.2.2 (Applied Biosystems; Foster City, CA,
USA). The levels of gene expression were expressed in
the form of 2-△△Ct and normalized to expression levels
of the β-actin internal housekeeping gene. Gene expres-
sion for each antibody treatment was calculated as the
mean of 2 duplicate wells in a single culture, which each
experiment was repeated by 6 times.Statistical analysis
Differences between immunized and control groups, in
terms of anti-inhibin α-subunit titer and concentrations
of E2, were analyzed by one-way analysis of variance
(ANOVA). Differences in gene and protein expression
in granulosa cells were analyzed by ANOVA. The
means were compared using the least significant
difference method. All values we expressed as mean
+/− SEM. All statistical analyses were performed with
SAS software Version 8.01 (SAS Institute Inc.; Cary,
NC, USA).
Table 1 Primers used in the real-time quantitative PCR assay of genes
Gene Accession number Primer sequences (5′-3′) Length (bp)
β-actin L08165 upstream: CCGAGAGAGAAATTGTGCGTGAC 166
downstream: TCGGGGCACCTGAACCTCTC
P450arom NM_214429.1 upstream: GGTCACAACAAGACAGGA 168
downstream: AACCAAGAGAAGAAAGCC
P450scc L34259.1 upstream: CCTGGGGGAGATAACGGTG 112
downstream: ATGCGGAAGGCGGGGCTG
StAR AY368628.1 upstream: CATTACCATCTACTCCCAGC 109
downstream: AACCCGTATCTTTCTTGTCAG
FSHR NM_214386.2 upstream: GCCCAGAACTAAAACACAATG 107
downstream: TATAGACAAGTAACCGTCAGC
LHR JN120797.1 upstream: TCAAGCCGAACTTTATAGACG 101
downstream: ATGTGGTCAACTTCAATGTGG
VEGF JF831364.1 upstream: CTGTTTCTCTTGAGGGCAATC 126
downstream: TATGGGAGGGTAGGGTGAG
FGF-2 XM_005666885.1 upstream: TGCTATGAAGGAAGATGGAAG 105
downstream: CTCGACCGGTAAGTATTGTAG
THBS1 NM_011580.3 upstream: TCGACTGTGAGAAGATGGAGAA 112
downstream: GTTGTCAAGGGTGACAAAGACA
ADAMTS JQ065373.1 upstream: CTCCTACCTTTCTTTCCTC 123
downstream: TCTTGTTCTGGCATTACATC
TIMP NM_001145985.1 upstream: CGGAGGAAAGAAGGAGTA 190
downstream: GGAGATGTAGCAGGGGAT
IGF-1 NM_214256.1 upstream: AAGAAGGGTCACAACAAG 176
downstream: CAAACCAAGAGAAGAAAG
IGF-2 X56094.1 upstream: TGGCATCGTGGAAGAGTG 166
downstream: CCAGGTGTCATAGCGGAA
IGFBP2 HQ432890.1 upstream: ATGTCAGGCTAGTCTCTC 124
downstream: TGGTATGTAACTTGGGGA
IGFBP5 NM_214099.1 upstream: TCCAGTACGAAATCAAGC 114
downstream: TTCCTCCGATGTCCAGCG
FN1 XM_003133641.2 upstream: AATTGGCTTGGTCTGTAT 104
downstream: CGGTCGTGATGGTATGTG
Cyclin D1 XM_003468321.2 upstream: GAAATCAAGCAGATAAAG 178
downstream: CGATGAAGTCACAGAGCG
P27kip NM_214316.1 upstream: TGCCTTTAATTGGGTCTC 158
downstream: GTTGGCTCTTTTGTTTTG
BCL 2 NM_214285.1 upstream: CATGCGTATTTATATTTG 112
downstream: CTCTGCTGCTTGCTGCTA
caspase-3 NM_214131.1 upstream: ATGTCAGGCTAGTCTCTC 124
downstream: TGGTATGTAACTTGGGGA
FOXL2 NM_001244665.1 upstream: TGGCATCGTGGAAGAGTG 166
downstream: CCAGGTGTCATAGCGGAA
c-FOS NM_001123113.1 upstream: TGGCATCGTGGAAGAGTG 166
downstream: CCAGGTGTCATAGCGGAA
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Table 1 Primers used in the real-time quantitative PCR assay of genes (Continued)
CEBP AY207000.1 upstream: AGACGCAGCATAAGGTCC 104
downstream: CTTGAACAAGTTCCGCAG
INHα DQ356013.1 upstream: AGACCTTCGTGGTTATTT 108
downstream: TGGCTACAGCTCTGATTC
INHβ NM_001164842.1 upstream: TAATGGAATAACAAATGG 164
downstream: AGGCAGAAGGAAGGGAGA
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E2 secretion
Treatment with anti-inhibin α-subunit antibodies in-
creased E2 concentrations in conditioned supernatants
from the granulosa cell culture in a dose-dependent
manner. The highest E2 concentration was 7814.68 pg/mL
following treatment with 200 μg/mL antibody. E2
concentration decreased further in the presence of a
higher (300 μg/mL) antibody concentration (Figure 1).
When both anti-inhibin α-subunit antibody and FSH
were added to the culture medium, we observed an
interaction between the two treatments. Without the
antibody, FSH treatment led to a dose-dependent increase
in E2 secretion, which plateaued at 3000 pg/mL at FSH
concentrations of 20 ng/mL. The anti-inhibin α-subunit
antibody appeared to attenuate the stimulatory effect
induced by FSH, especially at the concentrations of 25
and 50 g/mL. But at 100 g/mL antibody concentration,
inclusion of varying levels of FSH into the medium did
not affect E2 concentrations, which were indifferent from
that by anti-inhibin α-subunit antibody treatment alone
(Figure 2).Figure 1 Estradiol concentration by cultured porcine granulosa
cells in response to anti-inhibin α-subunit antibody treatment at
varying concentrations (0, 50, 100, 200, 300 μg/mL). Each value
(plus SEM) represents the average of data from 6 independent culture
experiments, each with 3 replicate wells. Means marked with different
letters are significantly different (a-b, b-c, c-d, c-e, d-e: P < 0.01).Cell proliferation
As an indirect measure of cellular proliferation, the re-
sults from the MTT assay revealed that treatment with
an anti-inhibin α-subunit antibody stimulated granulosa
cell proliferation in a dose- and time-dependent manner.
After 24 h of culture, the antibody slightly, but not sig-
nificantly, increased the formazan OD value. At 48 and
72 h, inclusion of the anti-inhibin α-subunit antibody
significantly (P < 0.05) increased the formazan OD value,
indicating an increased rate of cellular proliferation
(Figure 3).
Protein phosphorylation
As shown in Figure 4, treatment of granulosa cells with
an anti-inhibin α-subunit antibody increased the levels
of phosphorylated Smad3, PKA, and FOXL2 relative to
the level of the housekeeping protein β-actin.
Gene expression
Expression levels of the 26 genes assayed exhibited
either up- or downregulation following anti-inhibin α-
subunit antibody treatment during granulosa cell cultureFigure 2 Estradiol concentration by cultured porcine granulosa
cells in response to treatments of varying concentrations of anti-
inhibin α-subunit antibody (0, 25, 50, and 100μg/mL) and FSH (0,
10, 20, and 50 ng/mL). Each value (plus SEM) represents the average
of data of 6 independent culture experiments, each with 3 replicate
wells. Means marked with different letters are significantly different
(a-b, b-c: P < 0.05; a-c, a-d, b-d, c-d: P < 0.01).
Figure 3 Proliferation (represented by the MTT OD value) of
porcine granulosa cells following culture for varying times and in
response to different concentrations (0, 50, 100, and 200 μg/mL)
of anti-inhibin α-subunit antibody treatment. Each value (plus
SEM) represents data of 6 independent culture experiments, each
with 3 duplicate wells. Means marked with different letters are
significantly different (a-b, b-c: P < 0.05; a-c: P < 0.01).
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of sex hormone secretion (FSHR, LHR, StAR, P450arom,
and P450scc) was upregulated following anti-inhibin α-
subunit antibody treatment. The same was true for growth
factors and related factors (IGF1, IGF2, VEGF, FGF2,
IGFBP2, IGFBP5, IHNα, and IHNβ), cell proliferation- and
cell cycle-regulating genes (FN1, cyclinD1, and cyclinD2),
anti-apoptotic or anti-atresia genes (BCL2, TIMP, and
ADAMTS), and genes involved in follicular development,
as well as function-related transcription factors (FOXL2,
FOS, CEBP). Downregulated genes included THBS1, the
cell cycle regulatory factor p27kip, and the gene encoding
the apoptotic protein caspase-3.Figure 4 Expression levels of phosphorylated FOXL2, PKA, and Smad
varying concentrations (0, 50, and 200 μg/mL) of anti-inhibin α-subun
value (plus SEM) represents the average data of 4 independent culture exp
letters are significantly different (a-b: P < 0.01).Discussion
This study investigated the impact of anti-inhibin α-
subunit antibody treatment on granulosa cell function to
determine the mechanisms of enhanced ovarian follicular
development observed following inhibin immunization.
The results of this study showed that treating cultured
porcine granulosa cells with an anti-inhibin α-subunit
antibody significantly augmented cell function in terms of
E2 secretion and cell proliferation. These responses were
due to significant changes in the expression patterns of
genes coding for proteins associated with steroid hormone
synthesis, transcription factors, and cell apoptosis, growth,
and proliferation. These results suggest that treatment
with an anti-inhibin α-subunit antibody has widespread
effects on gene expression in granulosa cells.
Inhibin is a negative regulator of ovarian follicular de-
velopment, due to its inhibitory effect on pituitary go-
nadotropin FSH secretion [13]. Furthermore, inhibin
antagonizes the stimulatory effect of activin on follicular
development [5,14]. Inhibin precursors have been found
to compete with FSH binding at its receptor, FSHR,
which reduces FSHR signaling and subsequent FSH
stimulation of granulosa cell function [15]. In animal
models, immunization against inhibin has been shown to
stimulate the secretion of pituitary FSH, ovarian activin,
and E2, leading to enhanced follicular development and
supra-normal ovulation [6,10,16-18]. Enhanced ovarian
follicular function is illustrated by follicular growth and in-
creased hormone secretion capacity. Both these activities
are affected by pituitary FSH, growth factors secreted by
granulosa cells, and transforming growth factor family
members, including inhibin [4,19-21]. The effects of
these factors are mediated by complex intracellular
signal pathways that induce protein phosphorylation,
leading to enhanced transcription and gene expression
of key molecules in granulosa cells.3 proteins in cultured porcine granulosa cells in response to
it antibody treatment, normalized to β-actin expression. Each
eriments, each with 2 duplicate wells. Means marked with different
Figure 5 mRNA expression levels of cultured porcine granulosa cells in response to varying concentrations (0, 50, and 200 μg/mL) of
anti-inhibin α-subunit antibody treatment, normalized to β-actin expression. Each value (plus SEM) represents the average of data from 6
independent culture experiments, each with 3 duplicate wells. Means marked with different letters are significantly different (a-b: P < 0.05; a-c, a-d,
b-c, c-d: P < 0.01).
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inhibin or its α-subunit stimulated ovarian follicle
development and enhanced E2 secretion, which was
frequently accompanied by enhanced pituitary FSH secre-
tion [10,22,23]. By utilizing an in vitro cell culture method,
which excluded interference from pituitary-secreted FSH,
we were able to elucidate the regulatory effects exerted
solely by inhibin on granulosa cells. For example, immu-
noneutralization of inhibin by the addition of an anti-
inhibin α-subunit antibody into the cell culture medium
led to a significant increase in E2 secretion in the present
study. This result is consistent with the enhanced E2 se-
cretion observed following the treatment of bovine granu-
losa cells with an anti-inhibin α-subunit antibody, as well
as its attenuation following treatment with inhibin A [12].
Furthermore, the present study showed that anti-inhibin
α-subunit treatment led to a significant increase in E2
concentration in the culture medium, reaching 7814.68 pg/mL, which is similar to the level observed in the previ-
ous bovine study [12]. Although neither activin nor
inhibin concentration was measured in the cell culture
medium, it is expected that both would be synthesized
and secreted by granulosa cells, as mRNA for both the
inhibin-α and -β subunits was detected and upregulated
by anti-inhibin α-subunit treatment. Thus, the effects
of inhibin immunoneutralization should be realized by
a reduction in the inhibin/activin ratio in the culture
system, which should reduce the antagonizing effect in-
duced by inhibin, and thereby enhance activin binding
to the ACTRII receptor. The enhanced activin stimulation
will promote E2 secretion by cultured granulosa cells. This
hypothesis is supported by the finding that anti-
inhibin α-subunit treatment increased Smad3 phos-
phorylation, an intracellular ACTR signal transduction
molecule, in cultured porcine granulosa cells in the
present study.
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α-subunit antibody and FSH was observed in the regula-
tion of E2 secretion by granulosa cells. FSH stimulation
of E2 secretion in cultured porcine granulosa cells was
augmented by anti-inhibin α-subunit antibody treatment
at a concentration of 25 μg/mL. When the concentration
was increased (50 μg/mL), the effect of FSH was com-
promised, resulting in a reduction in E2 concentration
to almost 80% of the maximal level. Although this result
appears highly unlikely, it is nevertheless supported by
previous findings showing that high (100 ng/mL) and
low (3–30 ng/mL) concentrations of activin respectively
prevented and enhanced FSH receptor [24] and aroma-
tase activity [25] in cultured rat granulosa cells. Our re-
sults are also in line with the impaired development of
cultured rat follicles when cells were co-stimulated with
FSH and activin. The impaired FSH effect was consid-
ered to have been caused by inhibin production in the
rat study [17]. Thus, under very high (100 μg/mL) con-
centration of anti-inhibin antibody, which readily neu-
tralizes de novo secreted inhibin, E2 secretion was not
impaired by the addition of different FSH concentra-
tions. In the present study, we did not measure inhibin
concentration in the culture medium, because the anti-
body could interfere with the results, making it difficult
to determine the effect on E2 secretion by de novo se-
creted inhibin. Nevertheless, it also appears that the ef-
fect of FSH on E2 secretion is masked when a high
concentration of anti-inhibin antibody is present. Animal
experiments have consistently shown that enhanced
ovarian follicular E2 secretion is regulated by both anti-
inhibin α-subunit and FSH [10,22,23]; this same effect
could be equivalent to that brought about by the inter-
mediate, but not high, levels of antibody and FSH used
in this study. Enhanced E2 secretion could also arise be-
cause of a higher number of granulosa cells. Previous
findings showed no effect of inhibin treatment on the
proliferation of cultured granulosa cells [26,27], which
makes the role of inhibin in granulosa cell proliferation
inconclusive [5]. Nevertheless, the use of an anti-inhibin
α-subunit antibody in the present study led to enhanced
cell proliferation. This clearly suggests that inhibin may
exert an inhibitory effect on granulosa cell proliferation.
Such an effect could be mediated by antagonizing the
effects of activin, which (alone or in combination with
FSH) can exert profound promoting effects on the pro-
liferation of cultured bovine and rat granulosa cells
[21,27]. Thus, the use of an anti-inhibin α-subunit anti-
body in this study allowed us to overcome the disadvan-
tage of using inhibin directly.
In this study, immunoneutralization of inhibin led to the
activation of several transcription factors such as phos-
phorylated Smad3, PKA, and FOXL2 proteins, and mRNA
expression of CEBP and c-FOS. Immunoneutralization ofinhibin can increase the activin/inhibin ratio or create a
state of activin ‘tone’ [5,21] in the cell culture medium.
As a result, through ACTR signaling from de novo syn-
thesized and secreted activin, the expression of phos-
phorylated Smad3 is elevated in cultured granulosa
cells. Enhanced Smad3-mediated signaling can upregu-
late gene expression of FSHR and its signal pathway
molecule PKA [28], and also potentiates the ovarian re-
sponse to FSH stimulation [29]. Moreover, phosphoryl-
ation of PKA was enhanced in this study, although no FSH
was added to the cell culture medium. Thus, enhancement
of both the ACTR and FSHR signaling pathways should
strengthen granulosa cell proliferation and function. Fur-
thermore, phosphorylation of FOXL2, the earliest marker
of ovarian differentiation and a key regulator of ovarian de-
velopment and function [30-32], was upregulated by treat-
ment with anti-inhibin α-subunit antibody, or increased
activin ‘tone’. Thus, PKA through interaction with CEBP,
together with Smad3, FOXL2, and c-FOS, modulate the
expression of key genes involved in granulosa cell differen-
tiation as well as steroidogenesis, such as StAR, P450scc,
P450Cyp17, and Cyp19A1 [33-38]. For example, in the
promoter region of the aromatase gene, Cyp19A1, there
exist CRE-like, FOXL2, and Smad3 response elements
in the proximal promoter, and c-fos AP family factor
and CRE response elements in the distal promoter
[34,35,39,40]. Furthermore, FOXL2 interacts with Smad3
and another transcription factor, CATA4, to regulate gran-
ulosa cell viability and apoptosis; in particular, FOXL2
inhibits cell cycle progression [41,42] and induces apop-
tosis, while the latter two factors suppress apoptosis [42].
PKA, via its downstream target CREB, stimulates granu-
losa cell proliferation [35]. It is clear that synergistic and
complex regulation mediated by these transcription fac-
tors contribute to enhanced E2 secretion and cell prolifer-
ation following immunoneutralization of inhibin.
Under the regulation of these transcription factors,
changes in granulosa cell functions are fulfilled by up- or
downregulating the expression of relevant genes. Therefore,
enhanced E2 synthesis induced by anti-inhibin α-subunit
treatment was accompanied by upregulated expression of
steroidogenic genes StAR, P450scc, and P450arom, as well
as FSHR, LHR, IHNα, and IHNβ. Since the balance of
cyclinD2 and p27kip expression determines cell cycle pro-
gression, meiosis, and proliferation [43], the upregulation
of the cell cycle progression factors cyclinD1 and cyclinD2,
and the downregulation of the anti-proliferation gene
p27kip should favor cell division or proliferation, as repre-
sented by the higher MTT values of cells treated with an
anti-inhibin α-subunit. Likewise, antibody treatment also
upregulated the expression of IGF-I, IGF-II, and the genes
encoding their binding proteins, IGFBP2 and IGFBP5. The
expression of the former two genes also promotes granu-
losa cell proliferation and E2 secretion, while the latter two
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tosis of cells and follicle atresia [4,19]. Upregulation of anti-
apoptotic genes (BCL2, TIMP, and ADAMTS) [44-46], and
downregulation of pro-apoptotic genes (caspase-3) will fur-
ther augment granulosa cell viability and cell density fol-
lowing treatment with anti-inhibin α-subunit antibody.
This will function to further uphold E2 secretion. Some
genes involved in vascularization or angiogenesis, namely,
FGF2 and VEGF, were also upregulated, while THBS1 ex-
pression was downregulated by treatment with anti-inhibin
α-subunit antibody. THBS1 inhibits VEGF expression in
the ovary via the low-density lipoprotein receptor-related
protein-1 [47]. Moreover, fibronectin 1, which plays a vital
role in extracellular matrix formation [48], was regulated in
anti-inhibin α-subunit antibody-treated cells. These results
indicate that anti-inhibin α-subunit antibody-treated granu-
losa cells also synthesize and secrete factors and substances
that can promote follicular growth, angiogenesis, and extra-
cellular matrix remodeling, while simultaneously resisting
apoptosis or follicle atresia.
Conclusions
These results suggest that immunoneutralization of in-
hibin bioactivity, through the augmentation of activin and
gonadotrophin receptor signaling pathways and regulation
of gene expression, permits the development of healthy
and viable granulosa cells. These molecular mechanisms
help to explain the overstimulation of ovarian follicular
development observed following inhibin immunization in
animal models.
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